“Our results suggest that oscillometry . . . may serve as valuable, noninvasive biomarkers for early detection, risk stratification, and longitudinal monitoring of IPF,” the authors concluded.

Two technology leaders, Dario Amodei, CEO of Anthropic, and Nandan Nilekani, co-founder and chairman of Infosys, on how AI’s promise will ultimately hinge on diffusion, not just innovation.

A new risk stratification model for idiopathic pulmonary fibrosis could shift treatment from passive monitoring to active, goal-oriented care.

Regulatory officials have granted Molbreevi priority review and assigned a goal date of Aug. 22, 2026. If approved, Molbreevi will be priced between $400,000 and $500,000 per year.

The allocation of $2.7 billion to three nuclear fuel developers by the Trump administration will revitalize the U.S. uranium enrichment industry and help ease potential nuclear fuel shortages for ...

A rare physiological case study shows how aerobic capacity, muscle adaptation, and oxygen use can remain remarkably intact well into the eighties.

Figure 1 - LIS Technologies Inc. (LIST) plans to develop its commercial laser enrichment facility, named the LEU-3 Facility, ...

Alger Small Cap Focus Fund reviews Q4 2025 performance and the impact of the artificial intelligence capital cycle. Read the ...

As artificial intelligence reshapes geopolitics, economies and democratic processes, one reality is becoming impossible to ignore: AI is no longer just a technology conversation. It is a power ...

The implementation of the agreement will thus become a test of whether “green trade” can advance climate goals through ...

University of Surrey researchers discovered a compound known as nanostructured sodium vanadate hydrate (NVOH) – a layered sodium-based material that naturally contains water within its crystalline ...

AI promises productivity gains but raises fears of job losses in India’s fragile labour market, highlighting urgent need for ...